|
SWAP70 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.373850E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.95000000000356E-06 |
| Normal-vs-Stage2 |
2.128600E-01 |
| Normal-vs-Stage3 |
9.052200E-01 |
| Normal-vs-Stage4 |
2.049000E-01 |
| Stage1-vs-Stage2 |
1.226980E-01 |
| Stage1-vs-Stage3 |
2.14029999999754E-05 |
| Stage1-vs-Stage4 |
1.32599999980165E-07 |
| Stage2-vs-Stage3 |
1.916020E-01 |
| Stage2-vs-Stage4 |
4.220200E-02 |
| Stage3-vs-Stage4 |
2.636600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.273540E-02 |
| Normal-vs-AfricanAmerican |
3.747200E-01 |
| Normal-vs-Asian |
4.018800E-01 |
| Caucasian-vs-AfricanAmerican |
5.782000E-01 |
| Caucasian-vs-Asian |
5.735800E-01 |
| AfricanAmerican-vs-Asian |
5.037800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.363600E-02 |
| Normal-vs-Female |
6.655900E-03 |
| Male-vs-Female |
2.601400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.119600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.678500E-03 |
| Normal-vs-Age(61-80Yrs) |
9.776300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.902800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.393600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.981400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.218000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.221430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.220190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.879200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.083100E-03 |
| Normal-vs-Grade 2 |
3.94280000004521E-06 |
| Normal-vs-Grade 3 |
5.988400E-01 |
| Normal-vs-Grade 4 |
7.291500E-02 |
| Grade 1-vs-Grade 2 |
1.263890E-02 |
| Grade 1-vs-Grade 3 |
2.919100E-03 |
| Grade 1-vs-Grade 4 |
7.36880000018481E-07 |
| Grade 2-vs-Grade 3 |
1.97869999996048E-06 |
| Grade 2-vs-Grade 4 |
1.71990000019662E-07 |
| Grade 3-vs-Grade 4 |
1.317820E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.89030000541379E-08 |
| Normal-vs-ccB subtype |
9.446200E-01 |
| ccA subtype-vs-ccB subtype |
3.78310005544336E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.172000E-02 |
| Normal-vs-N1 |
3.486800E-01 |
| N0-vs-N1 |
1.120800E-01 |
|
|
